Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |